Cardlytics (CDLX) Invested Capital (2016 - 2026)

Cardlytics has reported Invested Capital for 11 years, with the latest figure at -$4.0 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 103.64% year-over-year to -$4.0 million; the trailing twelve-month figure through Mar 2026 stood at -$4.0 million (down 103.64% YoY), and the FY2025 full-year result was $206.1 million, down 28.59% from the prior year.
• Invested Capital for Q1 2026 stood at -$4.0 million, down from $206.1 million in the prior quarter.
• The five-year high for Invested Capital was $711.7 million in Q1 2022, with the low at -$4.0 million in Q1 2026.
• Historically, Invested Capital has averaged $301.4 million across 5 years, with a median of $266.1 million in 2023.
• Annual changes were most pronounced in 2024 — Invested Capital jumped 96.71% — and 2026, when it plunged 103.64%.
• Cardlytics' Invested Capital stood at $211.6 million in 2022, then surged by 85.39% to $392.3 million in 2023, then declined by 26.44% to $288.6 million in 2024, then decreased by 28.59% to $206.1 million in 2025, then sank by 101.94% to -$4.0 million in 2026.
• The last three Invested Capital figures came in at -$4.0 million (Q1 2026), $206.1 million (Q4 2025), and $41.4 million (Q3 2025), per Business Quant data.